# Biotech Innovation Path Call **Funder:** EIT Health **Budget:** Up to €240,000 per project **Deadline:** 16 September 2026 **Consortium:** Required — minimum 2 HEIs from 2 different eligible EU Member States, plus at least 1 non-academic/industry partner; at least 1 HEI must be in an EIT RIS region **Application:** Single stage; application platform opens 15 July 2026 **Frequency:** One-off **Official call:** https://eithealth.eu/opportunity/biotech-innovation-path-call/ **Last updated:** 5 Jul 2026 ## Eligibility & scope Funds design and delivery of an EIT Label-certified Biotech pathway (personalised learning courses) within the Certified Innovation Path portfolio. Consortium must include ≥2 HEIs in ≥2 eligible Member States (at least one in an EIT RIS region) and ≥1 industry/non-academic partner. At least one HEI must be authorised to award ECTS credits. Focus on health biotech innovation, entrepreneurship, and translation to market-ready solutions across Europe. ## Summary The EIT Health Biotech Innovation Path Call funds the design and delivery of EIT Label-certified biotech learning pathways that blend innovation, entrepreneurship, and translational skills for European higher education. Consortia of at least two universities (at least one in an EIT RIS region) plus an industry partner can apply for up to €240,000 per project to develop and deliver these structured, accredited courses. This is a one-off call supporting EIT's Certified Innovation Path portfolio focused on building market-ready biotech talent across Europe. ## Who should apply - Higher education institutions (minimum 2 from different eligible EU Member States, at least 1 in an EIT RIS region) - Consortia led by universities with ECTS-awarding authority - Industry or non-academic partners embedded in the consortium (required) - Teams designing accredited biotech innovation and entrepreneurship curricula - Institutions committed to EIT Label certification standards ## Key dates - Application platform opens 15 July 2026; deadline 16 September 2026 - Single-stage evaluation - Up to €240,000 per project for pathway design and delivery ## Tips for applicants - The industry partner is mandatory, not optional, reviewers assess evidence of genuine co-design and co-delivery in the learning pathway, not just token involvement. - At least one HEI must be in an EIT RIS region (Eastern, Central, Southern Europe, or island states); strategic partner choice here strengthens geographic equity scoring. - ECTS credit accreditation is a gating criterion, confirm your lead institution holds the formal authority before submitting, as late discovery of ineligibility blocks the application. ## Frequently asked questions ### How much can we apply for in the Biotech Innovation Path Call? Up to €240,000 per project for design and delivery of the certified biotech learning pathway. ### Who must be in a Biotech Innovation Path consortium? Minimum 2 universities from different eligible EU Member States (at least 1 in an EIT RIS region), plus at least 1 industry or non-academic partner. At least one HEI must be authorised to award ECTS credits. ### When is the deadline for the Biotech Innovation Path Call? 16 September 2026. The application platform opens on 15 July 2026. ### Is the Biotech Innovation Path Call recurring? No, this is a one-off call within EIT's Certified Innovation Path portfolio. ### What topics should the biotech pathway cover? The pathway must focus on health biotech innovation, entrepreneurship, and translation to market-ready solutions, delivered as accredited learning courses carrying EIT Label certification. --- Source: [The Great Grantsby](https://grantsby.eu/grants/eit-health-biotech-innovation-path-call-2026-09) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying. **See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).